Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

uent to the acquisition. Acquired in-process research and development, a charge related to the purchase accounting of the OBS acquisition, totaled $3.8 billion for 2007. Equity income in 2007 totaled $2.0 billion, an increase of 40 percent compared to 2006.

Recent Developments

The company also offered the following summary of recent significant developments that have previously been announced, including:

-- Reported on results from two Phase II studies in patients with vascular

disease showing that TRA, a novel oral thrombin receptor antagonist,

does not increase the rate of major or minor bleeding in patients with

acute coronary syndrome or prior ischemic stroke when added to standard

antiplatelet therapy. (Announced Oct. 22, 2007)

-- Reported long-term follow-up results with the European Organization for

the Research and Treatment of Cancer Phase III trial that showed the

combination of TEMODAR (temozolomide) Capsules and radiation therapy

significantly prolonged survival in patients with glioblastoma

multiforme. (Announced Oct. 30, 2007)

-- Reported that the U.S. District Court for the District of Massachusetts

found no liability for Warrick Pharmaceuticals, the company's generic

subsidiary, in a class action lawsuit regarding average wholesale

prices for prescription products. (Announced Nov. 5, 2007)

-- Gained European Commission approval of PEGINTRON (peginterferon alfa-

2b) and REBETOL (ribavirin) combination therapy for retreating adult

patients with chronic hepatitis C whose prior treatment did not result

in a sustained response. (Announced Nov. 15, 2007)

-- Completed the acquisition of Organon BioSciences N.V. (Announced Nov.

19, 2007)

-- Merck/Schering-Plough Pharmaceuticals announced that an independent

panel of clinical and biostatistics experts had b
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...AM, Mass., Nov. 19 Arlington Medic...t the leading driver of antibiotic selection in no...ivity against gram-positive and gram-negative path...use nosocomial pneumonia, surveyed European physic...at provide appropriate coverage against common pat...
(Date:11/19/2009)...urgeons and recognized refractive and cataract sur... brought their fellow surgeons up-to-date on the l...ataract surgery, and ophthalmology in general at t...ology (AAO) annual meeting in San Francisco, Calif...Dr. David Huang, MD, Dr. Randy Epstein, Dr. Willia...
(Date:11/19/2009)...ovember 19 AFFiRiS AG will focus i...idate at an unexpectedly early,stage of developmen...into,Phase II clinical trial early in 2010. This d...pletion of two Phase I trials with the candidates,... on the first interim,analysis of the secondary en...
(Date:11/18/2009)...ble to find explosive materials and persons who ha..., the National Institute of Standards and Technolo...eland Security, has developed a new certified refe...2905, Trace Particulate Explosives. Compatible wit... be helpful in calibrating, testing and developing...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2
... to the memory and scientific accomplishments of D...ogenesis and vasculogenesis and shed light on the ...the newly released special double issue (Volume 6,... includes a series of papers that reflect the rese...ientists of his generation. Lymphatic Research a...
...s appointed Andrew Chisholm to the position of Vic...ndrew brings the right mix of energy and expertise...h the next level in terms of our market penetratio...cumetrics. "His knowledge of the medical diagnosti...s make him a key component of our growth strategy ...
... a leader in providing automated, molecular testin...been invited and has accepted to present at the JP...anuary 12-15, 2009 at the Westin St. Francis Hotel...Kureshy, President & CEO will provide an overv...13, 2009. , , About JPMorgan 27th Annual Healthca...
Other Biology Technology:Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology 2Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology 3Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics 2
(Date:11/19/2009)...ntries of the world. It is widely used for human c... It also is considered an exemplar plant species f...d genome architecture. The authors of the research...st description of the B73 maize genome to probe so...d plant biology. The ten papers consider maize cen...
(Date:11/19/2009)...ty in maize, also known as corn, researchers acros...t should pave the way to significant improvements ...nimal feed and fiber around the world. , The new...ype map, charts genetic diversity and recombinatio...he research team, led by U.S. Department of Agricu...
(Date:11/19/2009)...tainable farming, initially adopted to preserve so... role in maintaining a healthy climate, according ...idge and Los Alamos national laboratories. , ORN...ntial of the earth,s soils to sequester carbon, wi...could greatly reduce U.S. carbon emissions by as m...
Breaking Biology News(10 mins):PLoS Genetics 2009 maize genome collection 2PLoS Genetics 2009 maize genome collection 3PLoS Genetics 2009 maize genome collection 4ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Rate Regulation for Health Insurance 3A Biden Obama Administration Should Look to CAs Model Law Which Has Saved Drivers 2462 Billion Since 1988 58038 1Rate Regulation for Health Insurance 3A Biden Obama Administration Should Look to CAs Model Law Which Has Saved Drivers 2462 Billion Since 1988 58038 2Rate Regulation for Health Insurance 3A Biden Obama Administration Should Look to CAs Model Law Which Has Saved Drivers 2462 Billion Since 1988 58038 3Pharmaceutical Biotech Research Companies Support Newark Rx Assistance Program 58035 1Pharmaceutical Biotech Research Companies Support Newark Rx Assistance Program 58035 2Pharmaceutical Biotech Research Companies Support Newark Rx Assistance Program 58035 3Emergency Nurses Association Announces Corporate Supporters for 2009 Annual Conference 58031 1Emergency Nurses Association Announces Corporate Supporters for 2009 Annual Conference 58031 2
...ls that react with seawater to produce an electric...s develop a strategy to reduce the bycatch of shar...ng priority worldwide given diminished populations... with target species for baited lines, reducing fi... A recent study by NOAA scientists and colleagues...
...2001 the Talibans destroyed two ancient colossal B...ind those statues, there are caves decorated with ...e caves also suffered from Taliban destruction, as...day they have become the source of a major discove...performed at the European Synchrotron Radiation Fa...
...re what we eat, may be the latest recipe for succe...limate warming. Despite the recent popular attent... plate, aka food miles, Carnegie Mellon researcher... in an upcoming article in the prestigious Environ...tary choice, not food miles, which most determines...
Other Biology News:Can certain metals repel sharks from fishing gear? 2Can certain metals repel sharks from fishing gear? 3Synchrotron light unveils oil in ancient Buddhist paintings from Bamiyan 2Carnegie Mellon studies how climate change impacts food production 2
...lignment, 3D structure visualization, phylogenetic...rch and more; all in a single application. Ret...ot, sort and filter them in real-time Organize yo...ing and sorting Provides up-to-date articles from...
POLYCLONAL ANTIBODY PRODUCTION from Global Peptide Services, LLC.
Transfection Buffer from BD Biosciences Pharmingen
Uniform 13C, 15N, Labeling of Peptides and Proteins new from rPeptide, LLC
Biology Products: